ETFs most similar to BBP
The funds whose holdings overlap Virtus Biotech ETF the most, by weight. as of Apr 30, 2026SEC filing
By holdings overlap
| Fund | Category | Overlap with BBP | Fee | Assets | 1Y | Yield | Compare |
|---|---|---|---|---|---|---|---|
| BBPVirtus Biotech ETF | Biotech & Health Innovation | — | 0.34% | $131M | +45.2% | — | |
| XBIState Street SPDR S&P Biotech ETF | Biotech & Health Innovation | 42% | 0.35% | $9.9B | +45.8% | 0.35% | side by side |
| LABUDirexion Daily S&P Biotech Bull 3X ETF | Leveraged Equity | 33% | — | $553M | +123.0% | 0.37% | side by side |
| PBEInvesco Biotechnology & Genome ETF | Biotech & Health Innovation | 32% | 0.58% | $422M | +34.5% | 1.38% | side by side |
| IBBiShares Biotechnology ETF | Biotech & Health Innovation | 32% | 0.44% | $10.8B | +35.9% | 0.17% | side by side |
| FBTFirst Trust NYSE Arca Biotechnology Index Fund | Biotech & Health Innovation | 31% | 0.55% | $2.9B | +41.3% | — | side by side |
Overlap is the sum of the smaller of the two weights across every shared holding. Try any combination in the overlap tool.
Fund data comes from each fund's SEC filings and issuer disclosures and is shown with the date it is as of. SEC portfolio and flow filings become public about 60 days after the period they cover. Nothing here is investment advice; see Terms.